ImmunityBio, Inc.

Quarterly Report for period ending 2023-09-30

Quarterly Report for period ending 2023-06-30

Quarterly Report for period ending 2023-03-31

Annual Report for period ending 2022-12-31

Quarterly Report for period ending 2022-09-30

Quarterly Report for period ending 2022-06-30

Quarterly Report for period ending 2022-03-31

Annual Report for period ending 2021-12-31

Quarterly Report for period ending 2021-09-30

Quarterly Report for period ending 2021-06-30

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Exempt (Private) Offering

Annual report to security holders

Notice of Effectiveness

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

Exempt (Private) Offering

Withdrawal of amendment to a registration statement filed under the Securities Act

Post-effective amendment filed solely to add exhibits to a registration statement

Notice of Effectiveness

Post-effective amendment to a registration statement that is not immediately effective upon filing

Adcock Richard: Statement of changes in beneficial ownership of securities

Sachs David C.: Statement of changes in beneficial ownership of securities

LAUER REGAN J: Statement of changes in beneficial ownership of securities

Simon Barry J.: Statement of changes in beneficial ownership of securities

Cambridge Equities, LP: Major Shareholders

SOON-SHIONG PATRICK: Statement of changes in beneficial ownership of securities

Sachs David C.: Statement of changes in beneficial ownership of securities

Adcock Richard: Statement of changes in beneficial ownership of securities

LAUER REGAN J: Statement of changes in beneficial ownership of securities

Cambridge Equities, LP: Major Shareholders

Prospectus filed pursuant to Rule 424(b)(5)

Prospectus filed pursuant to Rule 424(b)(5)

Prospectus filed pursuant to Rule 424(b)(5)

Registration statement for specified transactions by certain issuers

Prospectus filed pursuant to Rule 424(b)(5)

A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S-3

Prospectus filed pursuant to Rule 424(b)(5)

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Prospectus filed pursuant to Rule 424(b)(5)

Registration statement for specified transactions by certain issuers

Definitive information statements

Preliminary information statement not related to a contested matter or merger/acquisition

Definitive proxy statements

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Definitive proxy statements

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Definitive information statements

Preliminary information statement not related to a contested matter or merger/acquisition

Definitive proxy statements

Definitive proxy statement relating to a merger, acquisition, or disposition